SCHEMBL432155

SCHEMBL432155

Brc1cccc2nsnc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.57
KDM4E B2RXH2 5/20 0.57
HSD17B10 Q99714 3/20 0.57
HIF1A Q16665 1/20 0.57
TXNRD1 Q16881 1/20 0.48
TXNRD3 Q86VQ6 1/20 0.48
TXNRD2 Q9NNW7 1/20 0.48
ALDH1A1 P00352 8/20 0.44
POLB P06746 2/20 0.44
HPGD P15428 3/20 0.42
CASP1 P29466 1/20 0.42
KMT2A Q03164 7/20 0.41
MEN1 O00255 6/20 0.41
PTPN11 Q06124 2/20 0.41
PKM P14618 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
DUSP3 P51452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL198065 0.76 MAPT (0.61) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL246997 0.75 MAPT (0.44) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL396206 0.73 MAPT (1.00) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL10843606 0.73 KDM4E (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL1821199 0.73 MAPT (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL3632810 0.73 MAPT (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL1172929 0.73 MAPT (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL762283 0.73 MAPT (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL13836503 0.73 MAPT (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1
SCHEMBL3424124 0.73 KDM4E (0.57) MAPTKDM4EHSD17B10HIF1ATXNRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117534535-B Strong conjugated organic small molecular material and preparation method and application thereof 齐鲁工业大学(山东省科学院) 2025-03-14 CN claimed
CN-116041343-B Organic magnetic material and preparation method and application thereof 浙江理工大学嵊州创新研究院有限公司 2024-10-22 CN claimed
CN-117534535-A Strong conjugated organic small molecular material and preparation method and application thereof 齐鲁工业大学(山东省科学院) 2024-02-09 CN claimed
CN-116041343-A Organic magnetic material and preparation method and application thereof 浙江理工大学嵊州创新研究院有限公司 2023-05-02 CN claimed
US-12583870-B2 Azaheteroaryl compound and application thereof SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2026-03-24 US disclosed
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 US disclosed
US-12509454-B2 Thiadiazolyl derivatives IDEAYA BIOSCIENCES, INC. (US) 2025-12-30 US disclosed
US-12404280-B2 Heterocyclic compound, and organic light-emitting element using same LT MATERIALS CO., LTD. (KR) 2025-09-02 US disclosed
US-20250270215-A1 IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2025-08-28 US disclosed
EP-3701249-B1 DETECTION METHOD UNIV QUEENSLAND (AU) 2025-07-09 EP disclosed
US-20250123206-A1 DETECTION METHOD UNIV QUEENSLAND (AU) 2025-04-17 US disclosed
CN-117534535-B Strong conjugated organic small molecular material and preparation method and application thereof 齐鲁工业大学(山东省科学院) 2025-03-14 CN disclosed
WO-2009111260-A1 PHENYLSULFONAMIDE-SUBSTITUTED, PYRAZOLO[1, 5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF WYETH (US) 2009-09-11 WO disclosed
WO-2009108838-A1 BRIDGED, BICYCLIC HETEROCYCLIC OR SPIRO BICYCLIC HETEROCYCLIC DERIVATIVES OF PYRAZOLO[1,5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF WYETH (US) 2009-09-03 WO disclosed
US-20090221762-A1 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS THE TRUSSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-09-03 US disclosed
US-20090197889-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES SPELMAN COLLEGE (US) 2009-08-06 US disclosed
CN-101497610-A Dithiazole ethylene compound containing 2,1,3-diazosulfide unit UNIV EAST CHINA SCIENCE & TECH (CN) 2009-08-05 CN disclosed
WO-2007081991-A9 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS UNIV PENNSYLVANIA (US) 2007-09-07 WO disclosed
WO-2007081991-A2 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-07-19 WO disclosed
CN-1906704-A Hole transport layer compositions and related diode devices UNIV NORTHWESTERN (US) 2007-01-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 MAPT 4800/4885KDM4E 3719/4885HSD17B10 440/4885
US-20090221762-A1 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS PML, ILK, PARG MAPT 83/4885KDM4E 4081/4885HSD17B10 3468/4885
US-12583870-B2 Azaheteroaryl compound and application thereof NR3C1, EED, EZH2 MAPT 4193/4885KDM4E 503/4885HSD17B10 632/4885
US-20090197889-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES MKI67, PCNA, CCNI MAPT 4618/4885KDM4E 1606/4885HSD17B10 4356/4885
US-12404280-B2 Heterocyclic compound, and organic light-emitting element using same CRY1, CYP1A1, CYP1B1 MAPT 1769/4885KDM4E 2411/4885HSD17B10 1067/4885
US-20250123206-A1 DETECTION METHOD OPRK1, OPRM1, SIGMAR1 MAPT 1302/4885KDM4E 4142/4885HSD17B10 1215/4885
US-12509454-B2 Thiadiazolyl derivatives POLD1, POLQ, DNA2 MAPT 2801/4885KDM4E 3903/4885HSD17B10 617/4885
US-20250270215-A1 IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS ALK, TGFBR1, TGFBR2 MAPT 2205/4885KDM4E 555/4885HSD17B10 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.